天士力：“温经汤颗粒”取得注册证

Group 1 - The core point of the article is that Tian Shi Li has received a drug registration certificate for its product "Wen Jing Tang Granules" from the National Medical Products Administration [1] - Tian Shi Li's revenue composition for the year 2024 is as follows: Traditional Chinese medicine accounts for 70.89%, chemical preparations for 15.38%, pharmaceutical commerce for 10.53%, biological drugs for 2.25%, and chemical raw materials for 0.61% [1] - As of the report, Tian Shi Li's market capitalization stands at 23.8 billion yuan [1]